The polyvalent streptococcus pneumoniae vaccine is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
This report aims to provide a comprehensive presentation of the global market for Polyvalent Streptococcus Pneumococcal Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polyvalent Streptococcus Pneumococcal Vaccines. This report contains market size and forecasts of Polyvalent Streptococcus Pneumococcal Vaccines in global, including the following market information:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Polyvalent Streptococcus Pneumococcal Vaccines companies in 2022 (%)
The global Polyvalent Streptococcus Pneumococcal Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
9-Valent Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines include GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Polyvalent Streptococcus Pneumococcal Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Type, 2022 (%)
9-Valent
13-Valent
23-Valent
Others
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital
Community Clinics
Public Health Agencies
Others
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues share in global market, 2022 (%)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
LG Chem
Merck
Panacea Biotec
AstraZeneca
Pfizer
Shire
Pnuvax Incorporated
Serum Institute
Shinogi
Shenzhen Kangtai Biological Products
SK Bioscience
Walvax Biotechnology
Eli Lilly
Abera
Sanofi
Genentech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Polyvalent Streptococcus Pneumococcal Vaccines, market overview.
Chapter 2: Global Polyvalent Streptococcus Pneumococcal Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Polyvalent Streptococcus Pneumococcal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polyvalent Streptococcus Pneumococcal Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Polyvalent Streptococcus Pneumococcal Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Polyvalent Streptococcus Pneumococcal Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polyvalent Streptococcus Pneumococcal Vaccines Overall Market Size
2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2022 VS 2032
2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales: 2018-2032
3 Company Landscape
3.1 Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.2 Top Global Polyvalent Streptococcus Pneumococcal Vaccines Companies Ranked by Revenue
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies
3.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies
3.5 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Polyvalent Streptococcus Pneumococcal Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Markets, 2022 & 2032
4.1.2 9-Valent
4.1.3 13-Valent
4.1.4 23-Valent
4.1.5 Others
4.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
4.2.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2024-2032
4.2.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
4.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
4.3.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2023
4.3.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2024-2032
4.3.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
4.4 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Community Clinics
5.1.4 Public Health Agencies
5.1.5 Others
5.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
5.2.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2024-2032
5.2.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
5.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
5.3.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2023
5.3.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2024-2032
5.3.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
5.4 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2022 & 2032
6.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
6.2.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2024-2032
6.2.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
6.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
6.3.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2023
6.3.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2024-2032
6.3.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2032
6.4.2 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2032
6.4.3 US Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.4.4 Canada Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.4.5 Mexico Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2032
6.5.2 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2032
6.5.3 Germany Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.5.4 France Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.5.5 U.K. Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.5.6 Italy Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.5.7 Russia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.5.8 Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.5.9 Benelux Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2032
6.6.2 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2032
6.6.3 China Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.6.4 Japan Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.6.5 South Korea Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.6.6 Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.6.7 India Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2032
6.7.2 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2032
6.7.3 Brazil Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.7.4 Argentina Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2018-2032
6.8.3 Turkey Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.8.4 Israel Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.8.5 Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
6.8.6 UAE Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 LG Chem
7.2.1 LG Chem Company Summary
7.2.2 LG Chem Business Overview
7.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.2.4 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 LG Chem Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.3.4 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Panacea Biotec
7.4.1 Panacea Biotec Company Summary
7.4.2 Panacea Biotec Business Overview
7.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.4.4 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Panacea Biotec Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.5.4 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.6.4 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Shire
7.7.1 Shire Company Summary
7.7.2 Shire Business Overview
7.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.7.4 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Shire Key News & Latest Developments
7.8 Pnuvax Incorporated
7.8.1 Pnuvax Incorporated Company Summary
7.8.2 Pnuvax Incorporated Business Overview
7.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.8.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Pnuvax Incorporated Key News & Latest Developments
7.9 Serum Institute
7.9.1 Serum Institute Company Summary
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.9.4 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Serum Institute Key News & Latest Developments
7.10 Shinogi
7.10.1 Shinogi Company Summary
7.10.2 Shinogi Business Overview
7.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.10.4 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Shinogi Key News & Latest Developments
7.11 Shenzhen Kangtai Biological Products
7.11.1 Shenzhen Kangtai Biological Products Company Summary
7.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.11.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Shenzhen Kangtai Biological Products Key News & Latest Developments
7.12 SK Bioscience
7.12.1 SK Bioscience Company Summary
7.12.2 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.12.4 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 SK Bioscience Key News & Latest Developments
7.13 Walvax Biotechnology
7.13.1 Walvax Biotechnology Company Summary
7.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.13.4 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Walvax Biotechnology Key News & Latest Developments
7.14 Eli Lilly
7.14.1 Eli Lilly Company Summary
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.14.4 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Eli Lilly Key News & Latest Developments
7.15 Abera
7.15.1 Abera Company Summary
7.15.2 Abera Business Overview
7.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.15.4 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 Abera Key News & Latest Developments
7.16 Sanofi
7.16.1 Sanofi Company Summary
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.16.4 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Sanofi Key News & Latest Developments
7.17 Genentech
7.17.1 Genentech Company Summary
7.17.2 Genentech Business Overview
7.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.17.4 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 Genentech Key News & Latest Developments
8 Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity, Analysis
8.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity, 2018-2032
8.2 Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Polyvalent Streptococcus Pneumococcal Vaccines Supply Chain Analysis
10.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
10.2 Polyvalent Streptococcus Pneumococcal Vaccines Upstream Market
10.3 Polyvalent Streptococcus Pneumococcal Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Polyvalent Streptococcus Pneumococcal Vaccines in Global Market
Table 2. Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
Table 9. List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2024-2032
Table 16. By Application ? Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2024-2032
Table 21. By Region ? Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2024-2032
Table 26. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2024-2032
Table 30. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2024-2032
Table 34. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2024-2032
Table 38. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2024-2032
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 48. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. LG Chem Company Summary
Table 51. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 52. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. LG Chem Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 56. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Panacea Biotec Company Summary
Table 59. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 60. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Panacea Biotec Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 64. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 68. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Shire Company Summary
Table 71. Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 72. Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Shire Key News & Latest Developments
Table 74. Pnuvax Incorporated Company Summary
Table 75. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 76. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Pnuvax Incorporated Key News & Latest Developments
Table 78. Serum Institute Company Summary
Table 79. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 80. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Serum Institute Key News & Latest Developments
Table 82. Shinogi Company Summary
Table 83. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 84. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Shinogi Key News & Latest Developments
Table 86. Shenzhen Kangtai Biological Products Company Summary
Table 87. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 88. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Shenzhen Kangtai Biological Products Key News & Latest Developments
Table 90. SK Bioscience Company Summary
Table 91. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 92. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. SK Bioscience Key News & Latest Developments
Table 94. Walvax Biotechnology Company Summary
Table 95. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 96. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Walvax Biotechnology Key News & Latest Developments
Table 98. Eli Lilly Company Summary
Table 99. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 100. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Eli Lilly Key News & Latest Developments
Table 102. Abera Company Summary
Table 103. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 104. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Abera Key News & Latest Developments
Table 106. Sanofi Company Summary
Table 107. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 108. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Sanofi Key News & Latest Developments
Table 110. Genentech Company Summary
Table 111. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 112. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Genentech Key News & Latest Developments
Table 114. Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 115. Global Polyvalent Streptococcus Pneumococcal Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2018-2023 (K Units)
Table 117. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2024-2032 (K Units)
Table 118. Polyvalent Streptococcus Pneumococcal Vaccines Market Opportunities & Trends in Global Market
Table 119. Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers in Global Market
Table 120. Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints in Global Market
Table 121. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials
Table 122. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials Suppliers in Global Market
Table 123. Typical Polyvalent Streptococcus Pneumococcal Vaccines Downstream
Table 124. Polyvalent Streptococcus Pneumococcal Vaccines Downstream Clients in Global Market
Table 125. Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type in 2022
Figure 2. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application in 2022
Figure 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2018-2032 (US$, Mn)
Figure 7. Polyvalent Streptococcus Pneumococcal Vaccines Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Polyvalent Streptococcus Pneumococcal Vaccines Revenue in 2022
Figure 9. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 11. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 12. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 15. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 16. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 20. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 21. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 22. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 23. US Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 28. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 29. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 37. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 41. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 43. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 44. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2018-2032
Figure 48. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2018-2032
Figure 52. Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Polyvalent Streptococcus Pneumococcal Vaccines by Region, 2022 VS 2032
Figure 54. Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
Figure 55. Marketing Channels
